Psychological status of women with miscarriage

Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of perinatal complications, postpartum depression as well as behavioral problems in children. Aim: to assess the prevalence of symptoms related t...

Full description

Saved in:
Bibliographic Details
Published inАкушерство, гинекология и репродукция Vol. 17; no. 6; pp. 740 - 750
Main Authors Salov, I. A., Naumova, I. V., Parshin, A. V., Lomovitskaya, M. V.
Format Journal Article
LanguageEnglish
Russian
Published IRBIS LLC 04.01.2024
Subjects
Online AccessGet full text
ISSN2313-7347
2500-3194
DOI10.17749/2313-7347/ob.gyn.rep.2023.462

Cover

Abstract Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of perinatal complications, postpartum depression as well as behavioral problems in children. Aim: to assess the prevalence of symptoms related to depression and anxiety in pregnant women with threatened abortion (ТА), non-developing pregnancy (NP) as well as those with physiological course of pregnancy (РР) in the first trimester of pregnancy; to reveal major predictors of psycho-emotional disorders in pregnant women. Materials and Methods . Three groups of pregnant women were stratified: 62 patients with TA, 60 patients with NP and 57 women with PP. Clinical history and physical examination were performed in all subjects. All pregnant women were assessed by Hamilton Anxiety Rating Scale and the Beck Depression Inventory. Results. It was found that the mean Beck’s score was significantly higher in NP vs. TA and PP groups (p < 0.05). Moreover, significant differences were also observed while comparing TA and PP groups (p = 0.037). Clinically important depression was found in 3.3 % NP women and in 1.6 % TA women. Preclinical depression was found in 13 % and 6.5 % women with NP and TA, respectively. The mean Hamilton scale score was significantly higher in NP vs. PP group (p < 0.05), but was comparable with that in TA group (p > 0.05). The mean score on the anxiety scale was significantly higher in TA vs. PP group (p = 0.001). Clinically significant mild to moderate anxiety was found in 4.9 % and 1.6 % TA and NP women, respectively. Mild anxiety symptoms were noted in 35.5 % of women with TA, 38.3 % of women with NP, and 15.7 % of women with PP. Multiple linear regression analysis revealed that a burdened obstetric history and the duration of the patient hospital stay had the strongest association with symptoms of depression and anxiety. Conclusion. Symptoms of prenatal anxiety and depression are widespread and should be identified in a timely manner. Psychological counseling and testing of pregnant women should be included into recommendations for pregnancy management.
AbstractList Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of perinatal complications, postpartum depression as well as behavioral problems in children.Aim: to assess the prevalence of symptoms related to depression and anxiety in pregnant women with threatened abortion (ТА), non-developing pregnancy (NP) as well as those with physiological course of pregnancy (РР) in the first trimester of pregnancy; to reveal major predictors of psycho-emotional disorders in pregnant women.Materials and Methods. Three groups of pregnant women were stratified: 62 patients with TA, 60 patients with NP and 57 women with PP. Clinical history and physical examination were performed in all subjects. All pregnant women were assessed by Hamilton Anxiety Rating Scale and the Beck Depression Inventory.Results. It was found that the mean Beck’s score was significantly higher in NP vs. TA and PP groups (p < 0.05). Moreover, significant differences were also observed while comparing TA and PP groups (p = 0.037). Clinically important depression was found in 3.3 % NP women and in 1.6 % TA women. Preclinical depression was found in 13 % and 6.5 % women with NP and TA, respectively. The mean Hamilton scale score was significantly higher in NP vs. PP group (p < 0.05), but was comparable with that in TA group (p > 0.05). The mean score on the anxiety scale was significantly higher in TA vs. PP group (p = 0.001). Clinically significant mild to moderate anxiety was found in 4.9 % and 1.6 % TA and NP women, respectively. Mild anxiety symptoms were noted in 35.5 % of women with TA, 38.3 % of women with NP, and 15.7 % of women with PP. Multiple linear regression analysis revealed that a burdened obstetric history and the duration of the patient hospital stay had the strongest association with symptoms of depression and anxiety.Conclusion. Symptoms of prenatal anxiety and depression are widespread and should be identified in a timely manner. Psychological counseling and testing of pregnant women should be included into recommendations for pregnancy management.
Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of perinatal complications, postpartum depression as well as behavioral problems in children. Aim: to assess the prevalence of symptoms related to depression and anxiety in pregnant women with threatened abortion (ТА), non-developing pregnancy (NP) as well as those with physiological course of pregnancy (РР) in the first trimester of pregnancy; to reveal major predictors of psycho-emotional disorders in pregnant women. Materials and Methods . Three groups of pregnant women were stratified: 62 patients with TA, 60 patients with NP and 57 women with PP. Clinical history and physical examination were performed in all subjects. All pregnant women were assessed by Hamilton Anxiety Rating Scale and the Beck Depression Inventory. Results. It was found that the mean Beck’s score was significantly higher in NP vs. TA and PP groups (p < 0.05). Moreover, significant differences were also observed while comparing TA and PP groups (p = 0.037). Clinically important depression was found in 3.3 % NP women and in 1.6 % TA women. Preclinical depression was found in 13 % and 6.5 % women with NP and TA, respectively. The mean Hamilton scale score was significantly higher in NP vs. PP group (p < 0.05), but was comparable with that in TA group (p > 0.05). The mean score on the anxiety scale was significantly higher in TA vs. PP group (p = 0.001). Clinically significant mild to moderate anxiety was found in 4.9 % and 1.6 % TA and NP women, respectively. Mild anxiety symptoms were noted in 35.5 % of women with TA, 38.3 % of women with NP, and 15.7 % of women with PP. Multiple linear regression analysis revealed that a burdened obstetric history and the duration of the patient hospital stay had the strongest association with symptoms of depression and anxiety. Conclusion. Symptoms of prenatal anxiety and depression are widespread and should be identified in a timely manner. Psychological counseling and testing of pregnant women should be included into recommendations for pregnancy management.
Author Lomovitskaya, M. V.
Salov, I. A.
Naumova, I. V.
Parshin, A. V.
Author_xml – sequence: 1
  givenname: I. A.
  orcidid: 0000-0002-0729-9995
  surname: Salov
  fullname: Salov, I. A.
  organization: Razumovsky Saratov State Medical University, Health Ministry of Russian Federation
– sequence: 2
  givenname: I. V.
  orcidid: 0000-0002-4220-1236
  surname: Naumova
  fullname: Naumova, I. V.
  organization: Razumovsky Saratov State Medical University, Health Ministry of Russian Federation
– sequence: 3
  givenname: A. V.
  orcidid: 0000-0001-8793-4786
  surname: Parshin
  fullname: Parshin, A. V.
  organization: Razumovsky Saratov State Medical University, Health Ministry of Russian Federation
– sequence: 4
  givenname: M. V.
  orcidid: 0009-0003-4036-6162
  surname: Lomovitskaya
  fullname: Lomovitskaya, M. V.
  organization: Razumovsky Saratov State Medical University, Health Ministry of Russian Federation
BookMark eNo90E1rwzAMBmAzOljX9T_ktFtS23Kc-DIYZR-FwXbYzsZx5DQljYudUfrvl7TbThKSeBHPLZn1vkdC7hnNWFEIteLAIC1AFCtfZc2pzwIeMk45ZELyKzLnOaUpMCVmY_93e0OWMe4opVyxcZXPSfYRT3brO9-01nRJHMzwHRPvkqPfY58c22Gb7NtoTQitafCOXDvTRVz-1gX5en76XL-mb-8vm_XjW2rH73haWgBXCECOYK10zDhJHagaRZXXihVWVpYzqRSAUE4is0whLyWjkpaCwYJsLrm1Nzt9CO3ehJP2ptXngQ-NNmFobYdaIs8VBVdaWQunlCmxAmaxzl1V1W7Kerhk2eBjDOj-8xjVZ0w9AekJSPtKj5h6xNQTph4x4Qd6UWzD
Cites_doi 10.1037/t00742-000
10.1016/S0165-0327(02)00432-9
10.1016/j.jad.2016.11.031
10.1111/j.2044-8341.1959.tb00467.x
10.1080/14767058.2022.2049748
10.1186/s12889-020-8293-9
10.1016/S0140-6736(21)00682-6
10.3949/ccjm.87a.19054
10.1016/j.jadohealth.2012.04.008
10.1016/j.clp.2011.06.007
10.1016/bs.irn.2019.11.002
10.1097/01.AOG.0000287065.59491.70
10.1016/j.jad.2018.04.012
10.1037/a0013242
10.1080/14767050701209560
10.3122/jabfm.2007.01.060058
10.1007/s00737-011-0249-8
10.1093/aje/kwf176
10.1080/01674820400024406
10.1186/s12884-021-04021-y
10.1016/j.jad.2020.07.046
10.1192/bjp.bp.116.187179
10.5498/wjp.v11.i7.325
10.1590/S1807-59322010001100013
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.17749/2313-7347/ob.gyn.rep.2023.462
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2500-3194
EndPage 750
ExternalDocumentID oai_doaj_org_article_6e25903f8c6d4f99a8eb31ced5fbbdf1
10_17749_2313_7347_ob_gyn_rep_2023_462
GroupedDBID AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
ID FETCH-LOGICAL-c1772-8c33f743e2e3cc6f1af60f39de4b5d917c6bc216993349f6e1c19e28610608413
IEDL.DBID DOA
ISSN 2313-7347
IngestDate Wed Aug 27 01:30:57 EDT 2025
Tue Jul 01 04:01:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
Russian
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1772-8c33f743e2e3cc6f1af60f39de4b5d917c6bc216993349f6e1c19e28610608413
ORCID 0000-0001-8793-4786
0000-0002-4220-1236
0009-0003-4036-6162
0000-0002-0729-9995
OpenAccessLink https://doaj.org/article/6e25903f8c6d4f99a8eb31ced5fbbdf1
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_6e25903f8c6d4f99a8eb31ced5fbbdf1
crossref_primary_10_17749_2313_7347_ob_gyn_rep_2023_462
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-04
PublicationDateYYYYMMDD 2024-01-04
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-04
  day: 04
PublicationDecade 2020
PublicationTitle Акушерство, гинекология и репродукция
PublicationYear 2024
Publisher IRBIS LLC
Publisher_xml – name: IRBIS LLC
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref25
ref20
ref22
ref21
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref17
  doi: 10.1037/t00742-000
– ident: ref7
  doi: 10.1016/S0165-0327(02)00432-9
– ident: ref20
  doi: 10.1016/j.jad.2016.11.031
– ident: ref16
  doi: 10.1111/j.2044-8341.1959.tb00467.x
– ident: ref25
  doi: 10.1080/14767058.2022.2049748
– ident: ref6
  doi: 10.1186/s12889-020-8293-9
– ident: ref8
  doi: 10.1016/S0140-6736(21)00682-6
– ident: ref9
– ident: ref2
  doi: 10.3949/ccjm.87a.19054
– ident: ref14
  doi: 10.1016/j.jadohealth.2012.04.008
– ident: ref12
  doi: 10.1016/j.clp.2011.06.007
– ident: ref13
  doi: 10.1016/bs.irn.2019.11.002
– ident: ref18
  doi: 10.1097/01.AOG.0000287065.59491.70
– ident: ref10
  doi: 10.1016/j.jad.2018.04.012
– ident: ref4
  doi: 10.1037/a0013242
– ident: ref15
  doi: 10.1080/14767050701209560
– ident: ref21
  doi: 10.3122/jabfm.2007.01.060058
– ident: ref23
  doi: 10.1007/s00737-011-0249-8
– ident: ref11
  doi: 10.1093/aje/kwf176
– ident: ref19
  doi: 10.1080/01674820400024406
– ident: ref1
  doi: 10.1186/s12884-021-04021-y
– ident: ref3
  doi: 10.1016/j.jad.2020.07.046
– ident: ref5
  doi: 10.1192/bjp.bp.116.187179
– ident: ref22
  doi: 10.5498/wjp.v11.i7.325
– ident: ref24
  doi: 10.1590/S1807-59322010001100013
SSID ssj0002911945
Score 2.2464817
Snippet Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of...
Introduction. During pregnancy, a woman becomes vulnerable to develop symptoms of depression and anxiety, which in turn are associated with increased risk of...
SourceID doaj
crossref
SourceType Open Website
Index Database
StartPage 740
SubjectTerms anxiety
beck depression inventory
depression
hamilton anxiety rating scale
pregnancy
Title Psychological status of women with miscarriage
URI https://doaj.org/article/6e25903f8c6d4f99a8eb31ced5fbbdf1
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2500-3194
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0002911945
  issn: 2313-7347
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELUQA2JBIECUL3lAbEkT27nEIyCqioGJSt2s2D53a1BoB_49Z6dU7cTCainR5Z1z956VvGPsoQoCK92WmfQBMoXCZy0RjUyDk61TFuqQ3D7fYTpTb_NqvjPqK34TNtgDD8CNAYmgFzI0DrwKWrcNyb_Soa-CtT4k4UNtbEdMxRos6B3WaUIx8ReZ1VLVR-wxVgiiO3q8XRx3Nl98L_Meo3elkLkCsdehdoz8U8eZnLKTDVXkT0OIZ-ygX5-zfK9i8fg_0PqLd4EnKwUej1U5pc61Pe2sBV6w2eT142WabWYeZI5Co-LkpAzU1VGgdA5C2QYogtQela08aSsH1okSiFZIpQNg6UqNoiEWBEVDHemSHS67JV4xLopAmhOjoQ-oRlGFJYpaS60sWpAKRqz-fU7zOVhbmCgJIkImImQiQqazhhAyhJCJCBlCaMSeIyzbq6JFdVqgxJlN4sxfibv-j5vcsGMKSqUzEXXLDlf9Gu-IJazsfdoQP2kRt-8
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Psychological+status+of+women+with+miscarriage&rft.jtitle=%D0%90%D0%BA%D1%83%D1%88%D0%B5%D1%80%D1%81%D1%82%D0%B2%D0%BE%2C+%D0%B3%D0%B8%D0%BD%D0%B5%D0%BA%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F+%D0%B8+%D1%80%D0%B5%D0%BF%D1%80%D0%BE%D0%B4%D1%83%D0%BA%D1%86%D0%B8%D1%8F&rft.au=I.+A.+Salov&rft.au=I.+V.+Naumova&rft.au=A.+V.+Parshin&rft.au=M.+V.+Lomovitskaya&rft.date=2024-01-04&rft.pub=IRBIS+LLC&rft.issn=2313-7347&rft.eissn=2500-3194&rft.volume=17&rft.issue=6&rft.spage=740&rft.epage=750&rft_id=info:doi/10.17749%2F2313-7347%2Fob.gyn.rep.2023.462&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6e25903f8c6d4f99a8eb31ced5fbbdf1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2313-7347&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2313-7347&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2313-7347&client=summon